Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Conditions: Prevention Interventions: Drug: Cabotegravir Tablets, for oral use.; Drug: Cabotegravir Extended-Release Injectable Suspension, for intramuscular use.; Drug: Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use; Procedure: Rectal Biopsies Sponsors: ANRS, Emerging Infectious Diseases Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials